These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 24119847)

  • 1. Role of vitamin D receptor activation in racial disparities in kidney disease outcomes.
    Essien U; Goel N; Melamed ML
    Semin Nephrol; 2013 Sep; 33(5):416-24. PubMed ID: 24119847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor 23, vitamin D, and health disparities among African Americans with chronic kidney disease.
    Saxena N; Gutiérrez OM
    Semin Nephrol; 2013 Sep; 33(5):448-56. PubMed ID: 24119850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial differences in markers of mineral metabolism in advanced chronic kidney disease.
    Jovanovich A; Chonchol M; Cheung AK; Kaufman JS; Greene T; Roberts WL; Smits G; Kendrick J;
    Clin J Am Soc Nephrol; 2012 Apr; 7(4):640-7. PubMed ID: 22383748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Race, Mineral Homeostasis and Mortality in Patients with End-Stage Renal Disease on Dialysis.
    Scialla JJ; Parekh RS; Eustace JA; Astor BC; Plantinga L; Jaar BG; Shafi T; Coresh J; Powe NR; Melamed ML
    Am J Nephrol; 2015; 42(1):25-34. PubMed ID: 26287973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic, Environmental, and Disease-Associated Correlates of Vitamin D Status in Children with CKD.
    Doyon A; Schmiedchen B; Sander A; Bayazit A; Duzova A; Canpolat N; Thurn D; Azukaitis K; Anarat A; Bacchetta J; Mir S; Shroff R; Yilmaz E; Candan C; Kemper M; Fischbach M; Cortina G; Klaus G; Wuttke M; Köttgen A; Melk A; Querfeld U; Schaefer F;
    Clin J Am Soc Nephrol; 2016 Jul; 11(7):1145-1153. PubMed ID: 27313313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct impact of vitamin D insufficiency on calcitriol levels in chronic renal failure and renal transplant patients: a role for FGF23.
    Mazzaferro S; Pasquali M; Pugliese F; Citterio F; Gargiulo A; Rotondi S; Tartaglione L; Conte C; Pirrò G; Taggi F
    J Nephrol; 2012; 25(6):1108-18. PubMed ID: 22383345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of diabetes mellitus on vitamin D metabolism in predialysis patients.
    Tanaka H; Hamano T; Fujii N; Tomida K; Matsui I; Mikami S; Nagasawa Y; Ito T; Moriyama T; Horio M; Imai E; Isaka Y; Rakugi H
    Bone; 2009 Nov; 45(5):949-55. PubMed ID: 19631779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment.
    Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
    Nephron Clin Pract; 2008; 110(1):c58-65. PubMed ID: 18724068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between a second and a third generation parathyroid hormone assay in hemodialysis patients.
    Gannagé-Yared MH; Farès C; Ibrahim T; Rahal ZA; Elias M; Chelala D
    Metabolism; 2013 Oct; 62(10):1416-22. PubMed ID: 23769129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Vitamin D Metabolites with Parathyroid Hormone, Fibroblast Growth Factor-23, Calcium, and Phosphorus in Dogs with Various Stages of Chronic Kidney Disease.
    Parker VJ; Harjes LM; Dembek K; Young GS; Chew DJ; Toribio RE
    J Vet Intern Med; 2017 May; 31(3):791-798. PubMed ID: 28186657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intact fibroblast growth factor 23 levels predict incident cardiovascular event before but not after the start of dialysis.
    Nakano C; Hamano T; Fujii N; Obi Y; Matsui I; Tomida K; Mikami S; Inoue K; Shimomura A; Nagasawa Y; Okada N; Tsubakihara Y; Rakugi H; Isaka Y
    Bone; 2012 Jun; 50(6):1266-74. PubMed ID: 22425694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between urinary kidney injury molecule-1 and blood bone metabolism markers in patients with chronic kidney disease
.
    Yin C; Cheng C; Wang J; Zhang L; Purrunsing Y; Yang G; Zeng M; Huang H; Ren W; Ye Y; Ma H; Xing C; Wang N
    Clin Nephrol; 2020 Feb; 93(2):65-76. PubMed ID: 31793871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D treatment in chronic kidney disease.
    Andress DL
    Semin Dial; 2005; 18(4):315-21. PubMed ID: 16076355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mineral abnormalities and long-term graft function in pediatric renal transplant recipients: a role for FGF-23?
    Wesseling-Perry K; Tsai EW; Ettenger RB; Jüppner H; Salusky IB
    Nephrol Dial Transplant; 2011 Nov; 26(11):3779-84. PubMed ID: 21441401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanistic study of the cause of decreased blood 1,25-Dihydroxyvitamin D in sepsis.
    Li CH; Tang X; Wasnik S; Wang X; Zhang J; Xu Y; Lau KW; Nguyen HB; Baylink DJ
    BMC Infect Dis; 2019 Dec; 19(1):1020. PubMed ID: 31791247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma Vitamin D Level and Change in Albuminuria and eGFR According to Sodium Intake.
    Keyzer CA; Lambers-Heerspink HJ; Joosten MM; Deetman PE; Gansevoort RT; Navis G; Kema IP; de Zeeuw D; Bakker SJ; de Borst MH;
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2119-27. PubMed ID: 26450935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III).
    de Boer IH; Ioannou GN; Kestenbaum B; Brunzell JD; Weiss NS
    Am J Kidney Dis; 2007 Jul; 50(1):69-77. PubMed ID: 17591526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast Growth Factor 23 and Risk of CKD Progression in Children.
    Portale AA; Wolf MS; Messinger S; Perwad F; Jüppner H; Warady BA; Furth SL; Salusky IB
    Clin J Am Soc Nephrol; 2016 Nov; 11(11):1989-1998. PubMed ID: 27561289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum 25-hydroxyvitamin D as an independent determinant of 1-84 PTH and bone mineral density in non-diabetic predialysis CKD patients.
    Tomida K; Hamano T; Mikami S; Fujii N; Okada N; Matsui I; Nagasawa Y; Moriyama T; Ito T; Imai E; Isaka Y; Rakugi H
    Bone; 2009 Apr; 44(4):678-83. PubMed ID: 19111635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal transplantation.
    Tomida K; Hamano T; Ichimaru N; Fujii N; Matsui I; Nonomura N; Tsubakihara Y; Rakugi H; Takahara S; Isaka Y
    Bone; 2012 Oct; 51(4):729-36. PubMed ID: 22796419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.